FR-194921

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

FR-194921

Specification
Cat. No.
SMD225
Related Diseases
Anxiety
Product Name
FR-194921
Size
Customizable
Price
Inquiry
Description
FR-194921 is a new potent, selective, and orally active antagonist for central adenosine A1 receptors. FR194921 showed potent and selective affinity for the adenosine A1 receptor without affinity for A2A and A3 receptors and did not show any species differences in binding affinity profile among human, rat, and mouse. FR194921 exerts both cognitive-enhancing and anxiolytic activity, suggesting the therapeutic potential of this compound for dementia and anxiety disorders.
CAS Number
202646-80-8
Chemical Formula
C23H23N5O
Exact Mass
385.19026
Molecular Weight
385.46
Elemental Analysis
C, 71.67; H, 6.01; N, 18.17; O, 4.15
Synonym
FR-194921; FR 194921; FR194921.
IUPAC/Chemical Name
3(2H)-Pyridazinone, 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-
InChi Key
YHDRUTMZCJZJAL-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H23N5O/c1-26-15-12-18(13-16-26)28-21(29)11-10-19(24-28)22-20-9-5-6-14-27(20)25-23(22)17-7-3-2-4-8-17/h2-11,14,18H,12-13,15-16H2,1H3
SMILES Code
O=C1C=CC(C2=C3C=CC=CN3N=C2C4=CC=CC=C4)=NN1C5CCN(C)CC5
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top